Introduction
============

Although microvascular decompression (MVD) for trigeminal neuralgia (TN) has been reported as an effective treatment modality,^[@B1]--[@B3]^ percutaneous treatments including glycerol rhizotomy (GR),^[@B4]--[@B9]^ radiofrequency thermocoagulation (RT),^[@B10]--[@B12]^ and balloon compression (BC)^[@B7],[@B13]--[@B16]^ are also useful for patients with severe TN. These percutaneous treatments are helpful for patients who have medical comorbidities and risk factors of MVD, and are especially suitable for the advanced elderly.^[@B5]^ The most important point in percutaneous treatments is to insert the nerve-block needle into the foramen ovale and place it in the trigeminal cistern accurately and safely. Traditionally, they are performed with a conventional fluoroscopy system.^[@B17]--[@B19]^ The foramen ovale can be seen with an anteroposterior oblique (APO) view, and surgeons speculate on the location of the needle tip with lateral X-ray views as two-dimensional (2-D) images. The junction of the posterior clivus and petrous bone is known to be near Meckel's cave; however, surgeons cannot precisely confirm the actual position of the needle tip. It is sometimes difficult to detect the foramen ovale even with an APO view. Surgeons need extensive experience to perform this procedure, and sometimes require a number of trials, which may cause some serious complications.^[@B6],[@B20]--[@B25]^

Some authors reported RT using computed tomography (CT) fluoroscopy to clearly show the real-time position of the nerve-block needle going to the foramen ovale.^[@B26]--[@B29]^ Neuronavigator-guided percutaneous RT has also been reported as a modern technique.^[@B30]--[@B32]^ Current techniques make percutaneous treatments accurate and safe. Here, we describe the technical details of GR using a single-plane, flat panel detector angiography system with cone-beam CT, which is used for examinations and endovascular treatment of cerebrovascular disease.

Materials and Methods
=====================

The patient is placed in a supine position with mild retroflexion on the bed of a single-plane angiography system (AXIOM Artis dFA; Siemens, Germany) under conscious sedation using diazepam or pentazocine ([Fig. 1a](#F1){ref-type="fig"}). Vital sign monitors including an electrocardiogram, blood pressure monitor, and pulse oximetry are always set to observe bradycardia and hypotension arising from the trigeminal depressor response. After local anesthesia, the procedure is performed according to Hartel's technique.^[@B17]--[@B19]^ A 22 G nerve-block needle is inserted at 2.5--3 cm lateral to the labial commissure, and it should be advanced toward a coronal landmark (the floor of the orbita under the ipsilateral pupil) and a sagittal landmark (3.5 cm anterior to the tragus at the lower border of the zygoma). According to these landmarks, surgeons advance the needle tip while conforming the foramen ovale with an APO view ([Fig. 1a, b](#F1){ref-type="fig"}), and the junction of the posterior clivus and petrous bone with a lateral view ([Fig. 1c, d](#F1){ref-type="fig"}) under fluoroscopy.

So far, our method is the same as the traditional method using conventional fluoroscopy; however, a flat panel detector angiography system can perform 2- and 3-D bone imaging by cone-beam CT. When the needle tip seems to be directed though the foramen ovale to the trigeminal cistern, we stop advancing the needle and perform cone-beam CT which immediately shows 2- and 3-D images of the needle position. The needle tip in the foramen ovale means that it is not located in the trigeminal cistern ([Fig. 2a, b](#F2){ref-type="fig"}). The needle tip on the outside of Meckel's cave means that it may be near the third-division in the trigeminal plexus ([Fig. 3a](#F3){ref-type="fig"}), the needle tip in the center may be in the second-division ([Fig. 3b](#F3){ref-type="fig"}), and the needle tip on the inside may be near the first-division ([Fig. 3c](#F3){ref-type="fig"}).

If it is difficult to advance the needle tip though the foramen ovale, numerous trials should not be performed blindly for a long time. Cone-beam CT should be conducted to check for inappropriate positioning of the needle ([Fig. 4a, b](#F4){ref-type="fig"}). Surgeons can understand where the needle tip is located and should be advanced. After confirming the positional relation between the needle tip and foramen ovale, the needle can be advanced in the precise direction. Finally, the needle tip can be placed in Meckel's cave and 3-D images should be taken again to verify the correct location of the needle tip. To confirm that the needle tip is in the trigeminal cistern, we always perform trigeminal cisternography after cone-beam CT. Glycerol (from 0.2 ml to 0.4 ml) is injected with the patients in a seated position, and they remain in the same position for 2 hours.^[@B4]--[@B9]^

We obtained written informed consent from the patient who is shown in [Fig. 1](#F1){ref-type="fig"} of this article, and sent the written informed consent form to the Neurologia medico-chirurgica editorial office.

Results
=======

Between July 2013 and September 2015, we conducted 10 procedures for seven patients with idiopathic TN who desired to undergo GR ([Table 1](#T1){ref-type="table"}). Preoperatively, we explained about surgical treatments of MVD, Gamma Knife radiosurgery (GKR), and GR, and all patients with intolerable pain desired GR. Seven procedures required cone beam CT once, and three procedures required it twice. The average time from the puncture to confirmation of the needle position with 3-D CT images was 14.5 minutes. All procedures needed only one trigeminal cisternography showing the needle tip in the trigeminal cistern. Except for three cases who could not take medicine because of allergy to carbamazepine (No. 5) and renal failure (Nos. 7 and 8), the other seven cases needed no medicine postoperatively. All patients achieved initial pain relief without complications associated with this method.

Discussion
==========

The percutaneous treatments including GR, RT, and BC have been shown to provide effective pain relief following injury to pain fibers in the trigeminal nerve. According to previous reports,^[@B5]^ these techniques provided similar effective pain relief: pain control rates up to 90% at 6 months and about 60% at 3 years. Commonly reported complications of these percutaneous treatments include dysesthesia (average, 8.3% in GR), masseter weakness (average, 3.1% in GR), and corneal numbness (average, 8.1% in GR); however, these side effects seem to be acceptable for patients with intolerable pain. Neuropathic pain has not been reported secondary to these percutaneous treatments. Although most patients in our cases complained of pain during the glycerol injection, this symptom seems to be correlated with a good pain outcome in GR. Recurrence rates are diverse: up to 35% within 5 years in the previous review of GR. Although RT seems to show a slightly better result compared with the two other procedures, we have performed GR as a percutaneous treatment for TN because we do not have instruments and materials for RF. GKR also demonstrates good pain control rates of 50--75% at 5 years.^[@B5]^ This noninvasive approach is not covered by insurance in Japan, being one of the reasons why patients did not desire GKR in this study.

During percutaneous procedures, inserting the needle into the foramen ovale and placing it at Meckel's cave is a key procedure. According to the traditional technique,^[@B17]--[@B19]^ the surgeons speculate on the position of the needle tip based on fluoroscopic images. Conventional C-arm fluoroscopy is usually conducted. The foramen ovale can be seen with an APO view; however, it cannot always be seen clearly. When the needle tip is located at the junction of the clivus and petrous bone with a lateral view, this suggests that the needle tip may have been inserted though the foramen ovale; however, surgeons cannot confirm the actual location of the needle tip. Numerous trials of inadequate punctures may cause not only anxiety during operations but also facial pain and postoperative hematoma. Some serious complications were rarely reported as injuries of the superior or inferior orbital fissure, carotid artery, cavernous sinus, and jugular foramen which caused blindness, abducens nerve palsy, or carotid-cavernous fistula.^[@B21],[@B22],[@B25]^ Moreover, subdural, subarachnoid, and intracranial hemorrhage have been reported.^[@B20],[@B23],[@B25]^ Sindou et al. described 10 false punctures in 200 procedures based on their abundant experience: 2 in the carotid artery canal, 1 in the jugular foramen, and 7 in the sphenoidal emissary foramen.^[@B24]^

To prevent these complications, new techniques of percutaneous treatments for TN have been reported. Some authors reported RT guided by high-speed real-time CT fluoroscopy.^[@B26]--[@B29]^ These techniques show the foramen ovale and nerve-block needle with 2- and 3-D images during operations. CT-guided percutaneous procedures can be used to precisely advance the needle tip to the trigeminal cistern. Recently, percutaneous treatments guided by neuronavigation and, moreover, CT with neuronavigation have been reported.^[@B30]--[@B32]^ These procedures are also ideal, and surgeons can obtain visual-spatial information.

Angiography systems with a flat panel detector are necessary for intervention therapy of neurosurgery, cardiovascular surgery, and medicine. We use this system for percutaneous treatments for TN instead of the conventional C-arm which usually is equipped with an image intensifier system. Compared with the conventional C-arm, an angiography system with a flat panel detector has advantages of not only reducing radiation exposure and improving image quality,^[@B33]--[@B35]^ but also provides the function of CT-like 3-D imaging using cone-beam CT.^[@B36]^ Surgeons can immediately check the position of the needle during procedures. Our procedure also has other advantages. Because neurosurgeons usually use angiography systems in their daily work, they can use them skillfully. We think that our method is convenient and useful for percutaneous treatments, including RT and BC. Although we had little experience of percutaneous treatments, with 10 procedures in 26 months, we could finish in about 14.5 minutes on average without complications. This simple technique will provide another therapeutic option for neurosurgeons treating TN.

Radiation exposure is the most significant problem regarding this procedure. Although the reduced radiation exposure from a flat panel detector is less than that using an image intensifier system,^[@B33]--[@B35]^ surgeons should perform cone-beam CT once or twice during operations. In our experience, this procedure is completed in 14.5 minutes on average; therefore, radiation exposure may be less than that with routine angiographical examinations.

![a: Intraoperative photograph showing the position of a patient and a single-plane angiography system with an anteroposterior oblique (APO) view to see the foramen ovale. b: APO fluoroscopic image showing the foramen ovale (*arrowhead*) and the needle tip going toward the foramen ovale. c: Intraoperative photograph showing an operator observing a lateral fluoroscopic image and advancing the needle. d: Lateral fluoroscopic image showing the needle tip going toward the junction of the posterior clivus and petrous bone.](nmc-56-257-g1){#F1}

![a: Three-dimensional bone image of cone-beam computed tomography (CT) showing the needle tip near Meckel's cave. b: Two-dimensional bone imaging of cone-beam CT showing the needle tip remaining in the foramen ovale, and not in Meckel's cave.](nmc-56-257-g2){#F2}

![a: A 3-D (three-dimensional) bone imaging of cone-beam computed tomography (CT) showing the needle tip (*arrow*) outside of Meckel's cave (*arrowhead*), which suggests that the needle tip may be near the third-division in the trigeminal plexus. b: A 3-D bone imaging of cone-beam CT showing the needle tip (*arrow*) in the center of Meckel's cave (*arrowhead*), which suggests that the needle tip may be near the second-division in the trigeminal plexus. c: A 3-D bone imaging of cone-beam CT showing the needle tip (*arrow*) inside of Meckel's cave (*arrowhead*), which suggests that the needle tip may be near the first-division in the trigeminal plexus.](nmc-56-257-g3){#F3}

![a, b: Three-dimensional bone imagings of cone-beam computed tomography showing the needle tip (*arrows*) remaining at the anterolateral edge of the foramen ovale (*arrowheads*).](nmc-56-257-g4){#F4}

###### 

Summary of glycerol rhizotomy for trigeminal neuralgia using angiography system

  Procedures (No.)   Offending trigeminal division   Time from puncture to 3-D CT (minutes)   Frequency of 3-D CT   Medication           Initial pain relief   
  ------------------ ------------------------------- ---------------------------------------- --------------------- -------------------- --------------------- --------------
  1                  V2.3                            14                                       1                     CBZ 400 mg           no                    satisfactory
  2                  V2.3                            26                                       2                     CBZ 400 mg           no                    satisfactory
  3                  V2.3                            11                                       1                     CBZ 400 mg           no                    satisfactory
  4                  V1.2                            12                                       1                     CBZ 600 mg           no                    satisfactory
  5                  V2                              15                                       2                     no (drug allergy)    satisfactory          
  6                  V2.3                            9                                        1                     GBP 800 mg           no                    satisfactory
  7                  V2.3                            26                                       2                     no (renal failure)   satisfactory          
  8                  V2.3                            7                                        1                     no (renal failure)   satisfactory          
  9                  V2                              10                                       1                     CBZ 600 mg           no                    satisfactory
  10                 V2                              15                                       1                     CBZ 400 mg           no                    satisfactory

CBZ: carbamazepine, GBP: gabapentin, GR: glycerol rhizotomy, No.: number, 3-D CT: 3-dimensional computed tomography.
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